Abstract
Polypeptide growth factors represent a diverse group of hormone—like agents that affect a variety of cellular processes including metabolic regulation, cell division, extension of processes (and other morphological changes), and the maintenance of viability (James and Bradshaw 1984). They differ from their more classical counterparts in that they are often synthesized in a variety of cells and usually enjoy a spectrum of target tissues. They also often use non-systemic transport mechanisms. However, they are highly similar to (even indistinguishable from) other classic polypeptide hormones in the manner in which they interact with target tissues. These similarities include the obligatory requirement for cell surface receptors, the nature of the transmembrane signals generated and their effects on gene expression including the genes affected. Therefore, while it is convenient to consider this group of substances in a separate category (hence the retention of the term “polypeptide growth factor”), it is clear that they are an important part of the endocrine system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abel JJ (1926) Crystalline insulin. Proc Natl Acad Sci USA 12: 132–136
Angeletti RH, Bradshaw RA, Wade RD (1971) Subunit structure and amino acid composition of mouse submaxillary gland nerve growth factor. Biochemistry 10: 463–469
Antoniades HN, Scher CD, Stiles CD (1979) Purification of human platelet-derived growth factor. Proc Natl Acad Sci USA 76: 1809–1813
Anzano MA, Roberts AB, Smith JM, Sporn MB, De Larco JE (1983) Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type a and type ß transforming growth factors. Proc Natl Acad Sci USA 80: 6264–6268
Armelin HA (1973) Pituitary extracts and steroid hormones in the control of 3T3 cell growth. Proc Natl Acad Sci USA 70: 2702–2706
Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB (1983) Transforming growth factor-ß in human platelets: identification of a major storage site, purification, and characterization. J Biol Chem 11: 7155–7160
Banting FG, Best CH (1922) The internal secretion of the pancreas. J Lab Clin Med 7: 251–266
Betsholtz C, Johnsson A, Heldin C-H, Westermark B, Lind P, Urdea MS, Eddy R, Shows TB, Philpott K, Mellor AL, Knott TJ, Scott J (1986) cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines. Nature 320: 695–699
Blundell TL, Cutfield JF, Cutfield SM, Dodson EJ, Dodson GG, Hodgkin DC, Mer-cola DA, Vijayan M (1971) Atomic positions in rhombohedral 2-zinc insulin crystals. Nature 231: 506–511
Bocchini V, Angeletti PU (1969) The nerve growth factor: purification as a 30,000molecular-weight protein. Proc Natl Acad Sci USA 64: 787–794
Bohlen P, Esch F, Wegemer D, Salk P, Dennert G (1983) Isolation and partial characterization of human T-cell growth factor. Biochem Biophys Res Commun 117: 623–630
Bueker ED (1948) Implantation of tumors in the hind limb field of the embryonic chick and developmental responses of the lumbosacral nervous system. Anat Rec 102: 369–390
Burgess AW, Nice EC (1985) Murine granulocyte-macrophage colony-stimulating factor. Methods Enzymol 116: 588–600
Burgess AW, Camakaris J, Metcalf D (1977) Purification and properties of colony-stimulating factor from mouse lung-conditioned medium. J Biol Chem 252: 1998–2003
Burgess AW, Metcalf D, Sparrow LG, Simpson RJ, Nice EC (1986) Granulocyte/macrophage colony-stimulating factor from mouse lung conditioned medium. Biochem J 235: 805–814
Byrne PV, Heit WF, March CJ (1986) Human granulocyte-macrophage colony-stimulating factor purified from a Hodgkin’s tumor cell line. Biochim Biophys Acta 874: 266–273
Cheifetz S, Weatherbee JA, Tsang ML-S, Anderson JK, Mole JE, Lucas R, Massagué J (1987) The transforming growth factor-ß system, a complex pattern of cross-reactive ligands and receptors. Cell 48: 409–415
Clark-Lewis I, Kent SBH, Schrader JW (1984) Purification to apparent homogeneity of a factor stimulating the growth of multiple lineages of hemopoietic cells. J Biol Chem 259: 7488–7494
Coffey RJ, Derynck R, Wilcox JN, Bringman TS, Goustin AS, Moses HL, Pittelkow MR (1987) Production and autoinduction of transforming growth factor-a in human keratinocytes. Nature 328: 817–820
Cohen S (1959) Purification and metabolic effects of a nerve growth-promoting protein from snake venom. J Biol Chem 234: 1129–1137
Cohen S (1960) Purification of a nerve-growth promoting protein from the mouse salivary gland and its neurocytotoxic antiserum. Proc Natl Acad Sci USA 46: 302–311
Cohen S (1962) Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the newborn animal. J Biol Chem 237: 1555–1562
Collins T, Ginsburg D, Boss JM, Orkin SH, Pober JS (1985) Cultured human endothelial cells express platelet-derived growth factor B chain: cDNA cloning and structural analysis. Nature 316: 748–750
Csejtey J, Boosman A (1986) Purification of human macrophage colony stimulating factor (CSF-1) from medium conditioned by pancreatic carcinoma cells. Biochem Biophys Res Commun 138: 238–245
Cutler RL, Metcalf D, Nicola NA, Johnson GR (1985) Purification of a multipotential colony-stimulating factor from pokeweed mitogen-stimulated mouse spleen cell conditioned medium. J Biol Chem 260: 6579–6587
Dart LL, Smith DM, Meyers CA, Sporn MB, Frolik CA (1985) Factors from a human tumor cell: characterization of transforming growth factor ß and identification of high molecular weight transforming growth factor a. Biochemistry 24: 5925–5931
Daughaday WH, Kipnis D (1966) The growth-promoting and anti-insulin actions of somatotropin. Recent Prog Horm Res 22: 49–99
Daughaday WH, Hall K, Raben M, Salmon WD Jr, Van den Brande JL, Van Wyk JJ (1972) Somatomedin: proposed designation for sulphation factor. Nature 235: 107
De Larco J, Pigott DA, Lazarus JA (1985) Ectopic peptides released by a human melanoma cell line that modulate the transformed phenotype. Proc Natl Acad Sci USA 82: 5015–5019
De Martin R, Haendler B, Hofer-Warbinek R, Gaugitsch H, Wrann M, Schlusener H, Seifert JM, Bodmer S, Fontana A, Hofer E (1987) Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-ß gene family. EMBO J 6: 3673–3677
Derynck R, Goeddel DV, Ullrich A, Gutterman JV, Williams RD, Bringman TS, Berger WH (1987) Synthesis of mRNAs for transforming growth factors a and ß and the epidermal growth factor receptor by human tumors. Cancer Res 47: 707–712
Deuel TF, Huang JS, Proffitt RT, Baenziger JU, Chang D, Kennedy BB (1981) Human platelet-derived growth factor: purification and resolution into two active protein fractions. J Biol Chem 256: 8896–8899
Dewhirst FE, Stashenko PP, Mole JE, Tsurumachi T (1985) Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1ß. J Immunol 135: 2562–2568
Dukovich M, Mizel SB (1985) Murine interleukin 1. Methods Enzymol 116:480–492
Esch F, Baird A, Ling N, Ueno N, Hill F, Denoroy L, Klepper R, Gospodarowicz D, Bohlen P, Guillemin R (1985) Primary structure of bovine pituitary basic fibroblast growth factor ( FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc Natl Acad Sci USA 82: 6507–6511
Farrar WL, Johnson H M, Farrar JJ (1981) Regulation of the production of immune in- terferon and cytotoxic T lymphocytes by interleukin 2. J Immunol 126: 1120–1125
Froesch ER, Burgi H, Muller WA, Humbel RE, Jakob A, Labhart A (1967) Non-suppressible insulin-like activity of human serum: purification, physicochemical and biological properties and its relation to total serum ILA. Recent Prog Horm Res 23: 565–616
Frolik CA, Dart LL, Meyers CA, Smith DM, Sporn MB (1983) Purification and initial characterization of a type ß transforming growth factor from human placenta. Proc Nat! Acad Sci USA 80: 3676–3680
Gery I, Schmidt JA (1985) Human interleukin-1. Methods Enzymol 116: 456–467
Gimenez-Gallego G, Rodney C, Bennett C, Rios-Candelore M, DiSalvo J, Thomas K (1985) Brain-derived acidic fibroblast growth factor: complete amino acid sequence and homologies. Science 230: 1385–1388
Gimenez-Gallego G, Conn G, Hatcher VB, Thomas KA (1986) The complete amino acid sequence of human brain-derived acidic fibroblast growth factor. Biochem Biophys Res Commun 138: 611–617
Goldwasser E, Kung K-H (1971) Purification of erythropoietin. Proc Natl Acad Sci USA 68: 697–698
Gospodarowicz D (1975) Purification of a fibroblast growth factor from bovine pituitary. J Biol Chem 250: 2515–2520
Gospodarowicz D, Bialecki H, Greenburg G (1978) Purification of the fibroblast growth factor activity from bovine brain. J Biol Chem 253: 3736–3743
Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G (1987) Structural characterization and biological functions of fibroblast growth factor. Endocr Rev 8: 95–114
Grabstein K, Eisenman J, Mochizuki D, Shanebeck K, Conlon P, Hopp T, March C, Gillis S (1986) Purification to homogeneity of B cell stimulating factor. J Exp Med 163: 1405–1414
Greene LA, Shooter EM (1980) The nerve growth factor: biochemistry, synthesis and mechanism of action. Annu Rev Neurosci 3: 353–402
Hapel AJ, Young IG (1988) Molecular biology of interleukin 3: a multilineage hemopoietic growth regulator. In: Schrader JW (ed) Lymphokines, vol 15. Academic, San Diego
Harada N, Kikuchi Y, Tominaga A, Takaki S, Takatsu K (1985) BCGF II activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151 K12). J Immunol 134: 3944–3951
Harper GP, Barde YA, Burnstock G, Carstairs JR, Dennison ME, Suda K, Vernon CA (1979) Guinea pig prostate is a rich source of nerve growth factor. Nature 279: 160–162
Hatake K, Motoyoshi K, Ishizaka Y, Sato M (1985) Purification of human urinary colony-stimulating factor by high-performance liquid chromatography. J Chromatogr 344: 339–344
Heldin C-H, Westermark B, Wasteson A (1979) Platelet-derived growth factor: purification and partial characterization. Proc Natl Acad Sci USA 76: 3722–3726
Heldin C-H, Westermark B, Wasteson A (1981) Platelet-derived growth factor: isolation by a large-scale procedure and analysis of subunit composition. Biochem J 193: 907–913
Heldin C-H, Johnsson A, Wennergren S, Wernstedt C, Betsholtz C, Westermark B (1986) A human osteosarcoma cell line secretes a growth factor structurally related to a homodimer of PDGF A-chains. Nature 319: 511–514
Henney CS, Kuribaysahi K, Kern DE, Gillis S (1981) Interleukin-2 augments natural killer cell activity. Nature 291: 335–336
Hirano T, Taga T, Nakano N, Yasukawa K, Kashiwamura S, Shimizu K, Nakajima K, Pyun KH, Kishimoto T (1985) Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSF-2). Proc Natl Acad Sci USA 82: 5490–5494
Hogue-Angeletti RA, Bradshaw RA (1979) Nerve growth factor in snake venoms. In: Lee CY (ed) Snake venoms. Springer, Berlin Heidelberg New York, pp 276–294 (Handbook of experimental pharmacology, vol 52 )
Ihle JN, Keller J, Henderson L, Klein F, Palaszynski E (1982) Procedures for the purification of interleukin 3 to homogeneity. J Immunol 129: 2431–2436
James R, Bradshaw RA (1984) Polypeptide growth factors. Annu Rev Biochem 53: 259–292
Jeng I, Bradshaw RA (1978) The preparation of nerve growth factor. In: Marks N, Rodnight R (eds) Research methods in neurochemistry, vol 4. Plenum, New York, pp 265–288
Jeng I, Andres RY, Bradshaw RA (1979) Mouse nerve growth factor: a rapid isolation procedure for the a and y subunits. Anal Biochem 92: 482–488
Johnsson A, Heldin C-H, Westermark B, Wasteson A (1982) Platelet-derived growth factor: identification of constituent polypeptide chains. Biochem Biophys Res Commun 104: 66–74
Kniep EM, Kniep B, Grote W, Conradt HS, Monner DA, Muhlradt PF (1984) Purification of the T lymphocyte growth factor interleukin-2 from culture media of human peripheral blood leukocytes (buffy coats). Eur J Biochem 143: 199–203
Kronheim SR, March CJ, Erb SK, Conlon PJ, Mochizuki DY, Hopp TP (1985) Human interleukin 1: purification to homogeneity. J Exp Med 161: 490–502
Lachman LB, Shih L-CN, Brown DC (1985) Interleukin 1 from human leukemic monocytes. Methods Enzymol 116: 467–479
Leibson HJ, Marrack P, Kappler JW (1981) B cell helper factors. I. Requirement for both interleukin 2 and another 40,000 mol wt factor. J Exp Med 154: 1681–1693
Lemmon SK, Bradshaw RA (1983) Purification and partial characterization of bovine pituitary fibroblast growth factor. J Cell Biochem 21: 195–208
Lemmon SK, Riley MC, Thomas KA, Hoover GA, Maciag T, Bradshaw RA (1982) Bovine fibroblast growth factor: comparison of brain and pituitary preparations. J Cell Biol 95: 162–169
LeRoith D, Adamo M, Shemer J, Waldbillig R, Lesniak MA, dePablo F, Hart C, Roth J (1988) Insulin-related materials in the nervous system of vertebrates and non-vertebrates: possible extrapancreatic production. Horm Metab Res 20: 411–420
Levi-Montalcini R, Angeletti PU (1968) Nerve growth factor. Physiol Rev 48: 534–569
Levi-Montalcini R, Booker B (1960) Destruction of the sympathetic ganglia in mammals by an anti-serum to a nerve growth protein. Proc Natl Acad Sci USA 46: 384–391
Levi-Montalcini R, Hamburger V (1951) Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J Exp Zoo1116: 321–363
Levi-Montalcini R, Hamburger V (1953) A diffusible agent of mouse sarcoma producing hyperplasia of sympathetic ganglia and hyperneurotization of viscera in the chick embryo. J Exp Zool 123: 233–288
Linsley PS, Hargreaves WR, Twardzik DR, Todaro GJ (1985) Detection of larger polypeptides structurally and functionally related to type I transforming growth factor. Proc Natl Acad Sci USA 82: 356–360
Luetteke NC, Michalopoulos GK (1985) Partial purification and characterization of a hepatocyte growth factor produced by rat hepatocellular carcinoma cells. Cancer Res 45: 6331–6337
Marez A, N’guyen T, Chevallier B, Clement G, Dauchel MC, Barritault D (1987) Platelet derived growth factor is present in human placenta: purification from an industrially processed fraction. Biochimie 69: 125–129
Marquardt H, Todaro GJ (1982) Human transforming growth factor: production by a melanoma cell line, purification, and initial characterization. J Biol Chem 257: 5220–5225
Marquardt H, Hunkapiller MW, Hood LE, Twardzik DR, De Larco JE, Stephenson JR, Todaro GJ (1983) Transforming growth factors produced by retrovirustransformed rodent fibroblasts and human melanoma cells: amino acid sequence homology with epidermal growth factor. Proc Natl Acad Sci USA 80: 4684–4688
Marquardt H, Hunkapiller MW, Hood LE, Todaro GJ (1984) Rat transforming growth factor type 1: Structure and relation to epidermal growth factor. Science 223: 1079–1082
Marquardt H, Lioubin MN, Ikeda T (1987) Complete amino acid sequence of human transforming growth factor type ß2. J Biol Chem 262: 12127–12131
Massagué J (1983) Epidermal growth factor-like transforming growth factor: isolation, chemical characterization, and potentiation by other transforming factors from feline sarcoma virus-transformed rat cells. J Biol Chem 258: 13606–13613
Massagué J (1984) Type ß transforming growth factor from feline sarcoma virus-transformed rat cells. isolation and biological properties. J Biol Chem 259: 9756–9761
Miyake T, Kung CK-H, Goldwasser E (1977) Purification of human erythropoietin. J Biol Chem 252: 5558–5564
Mizel SB, Mizel D (1981) Purification to apparent homogeneity of murine interleukin 1. J Immuno1126: 834–837
Mizel SB, Dukovich M, Rothstein J (1983) Preparation of goat antibodies against interleukin 1: use of an immunoadsorbent to purify interleukin 1. J Immunol 131: 1834–1837
Morrison RS, Sharma A, de Vellis J, Bradshaw RA (1986) Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture. Proc Natl Acad Sci USA 83: 7537–7541
Morrison RS, Kornblum HI, Leslie FM, Bradshaw RA (1987) Trophic stimulation of cultured neurons from neonatal rat brain by epidermal growth factor. Science 238: 72–75
Nicola NA, Metcalf D, Matsumoto M, Johnson GR (1983) Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. J Biol Chem 258: 9017–9023
Nister M, Hammacher A, Mellstrom K, Siegbahn A, Ronnstrand L, Westermark B, Heldin C-H (1988) A glioma-derived PDGF A chain homodimer has different functional activities from a PDGF AB heterodimer purified from human platelets. Cell 52: 791–799
Nomura H, Imazeki I, Oheda M, Kubota N, Tamura M, Ono M, Ueyama Y, Asano S (1986) Purification and characterization of human granulocyte colony-stimulating factor ( G-CSF ). EMBO J 5: 871–876
Nordan RP, Pumphrey JG, Rudikoff S (1987) Purification and NH2-terminal sequence of a plasmacytoma growth factor derived from the murine macrophage cell line P3 88D1. J Immunol 139: 813–817
Ohara J, Coligan JE, Zoon K, Maloy WL, Paul WE (1987) High-efficiency purification and chemical characterization of B cell stimulatory factor-1/interleukin 4. J Immunol 139: 1127–1134
Paetkau V, Riendeau D, Bleackley RC (1985) Murine interleukin 2. Methods Enzymol 116: 526–539
Pattison SE, Dunn MF (1975) On the relationship of zinc ion to the structure and function of the 7S NGF protein. Biochemistry 14: 2733–2739
Paul J (1970) Cell and tissue culture, 4th edn. Churchill Livingston, Edinburgh
Pierson RW Jr, Temin HM (1972) The partial purification from calf serum of a fraction with multiplication-stimulating activity for chicken fibroblasts in cell culture and with non-suppressible insulin-like activity. J Cell Physiol 79: 319–329
Raines EW, Ross R (1982) Platelet-derived growth factor: high yield purification and evidence for multiple forms. J Biol Chem 257: 5154–5160
Rall LB, Scott J, Bell GI, Crawford RJ, Penschow JD, Niall HD, Coghlan JP (1985) Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues. Nature 313: 228–231
Rall LB, Scott J, Bell GI (1987) Human insulin-like growth factor I and II messenger RNA: isolation of complementary DNA and analysis of expression. Methods Enzymo 146: 239–248
Richmond A, Lawson DH, Nixon DW, Chawla RK (1985) Characterization of autostimulatory and transforming growth factors from human melanoma cells. Cancer Res 45: 6390–6394
Riendeau D, Harnish DG, Bleackley RC, Paetkau V (1983) Purification of mouse interleukin 2 to apparent homogeneity. J Biol Chem 258: 12114–12117
Rinderknecht E, Humbel RE (1976a) Polypeptides with nonsuppresible insulin-like and cell-growth promoting activitites in human serum: isolation, chemical characterization, and some biological properties of forms I and II. Proc Nat] Acad Sci USA 73: 2365–2369
Rinderknecht E, Humbel RE (1976b) Amino-terminal sequences of two polypeptides from human serum with nonsuppressible insulin-like and cell-growth-promoting activities: evidence for structural homology with insulin B chain. Proc Natl Acad Sci USA 73: 4379–4381
Rinderknecht E, Humbel RE (1978) Primary structure of human insulin-like growth factor II. FEBS Lett 89: 283–286
Robb RJ (1985) Human interleukin 2. Methods Enzymol 116: 493–525
Robb RJ, Kutny RM, Chowdhry V (1983) Purification and partial sequence analysis of human T-cell growth factor. Proc Natl Acad Sci USA 80: 5990–5994
Robb RJ, Kutny RM, Panico M, Morris HR, Chowdhry V (1984) Amino acid sequence and post-translational modification of human interleukin 2. Proc Natl Acad Sci USA 81: 6486–6490
Roberts AB, Anzano MA, Meyers CA, Wideman J, Blacher R, Pan Y-C, Stein S, Lehrman SR, Smith JM, Lamb LC, Sporn MB (1983) Purification and properties of a type ß transforming growth factor from bovine kidney. Biochemistry 22: 5692–5698
Ross R (1987) Platelet-derived growth factor. Annu Rev Med 38: 71–79
Ross R, Vogel A, Davies P, Raines E, Kariya B, Rivest M, Gustafson C, Glomset J (1979) The platelet-derived growth factor and plasma control cell proliferation. In: Sato GH, Ross R (eds) Hormones and cell culture. Cold Spring Harbor, New York, pp 5–16
Rubin JS, Bradshaw RA (1984) Preparation of guinea pig prostate epidermal growth factor. In: Barnes DW, Sirbasku DA, Sato GH (eds) Methods for preparation of media, supplements and substrata for serum free animal cell culture, vol 1. Liss, New York, pp 139–145
Rubin JS, Mariz I, Jacobs JW, Daughaday WH, Bradshaw RA (1982) Isolation and partial sequence analysis of rat basic somatomedin. Endocrinology 110: 734–740
Ryle AP, Sanger F, Smith LF, Kitai R (1955) The disulphide bonds of insulin. Biochem J 60: 541–556
Sanderson CJ, O’Garra A, Warren DJ, Klaus GGB (1986) Eosinophil differentiation factor also has B-cell growth factor activity: proposed name interleukin 4. Proc Natl Acad Sci USA 83: 437–440
Sasaki R, Yanagawa S-I, Chiba H (1987) Isolation of human erythropoietin with monoclonal antibodies. Methods Enzymol 147: 328–340
Seyedin SM, Thomas TC, Thompson AY, Rosen DM, Piez KA (1985) Purification and characterization of two cartilage-inducing factors from bovine demineralized bone. Proc Natl Acad Sci USA 82: 2267–2271
Seyedin SM, Thompson AY, Bentz H, Rosen DM, McPherson JM, Conti A, Siegel NR, Galluppi GR, Piez KA (1986) Cartilage-inducing factor-A: apparent identity to transforming growth factor-fl. J Biol Chem 261: 5693–5695
Sherwin SA, Twardzik DR, Bohn WH, Cockley KD, Todaro GJ (1983) High molecular weight transforming growth factor activity in the urine of patients with disseminated cancer. Cancer Res 43: 403–407
Smith KA, Lachman LB, Oppenheim JJ, Favata MF (1980) The functional relationship of the interleukins. J Exp Med 151: 1551–1556
Stanley ER (1985) The macrophage colony-stimulating factor, CSF-1. Methods Enzymol 116: 564–587
Stanley ER, Guilbert LJ (1981) Methods for the purification, assay, characterization and target cell binding of a colony stimulating factor (CSF-1). J Immunol Methods 42: 253–284
Stanley ER, Heard PM (1977) Factors regulating macrophage production and growth. J Biol Chem 252: 4305–4312
Stroobant P, Waterfield MD (1984) Purification and properties of porcine platelet-derived growth factor. EMBO J 12: 2963–2967
Takahashi M, Hong Y-M, Yasuda S, Takano M, Kawai K, Nakai S, Hirai Y (1988) Macrophage colony-stimulating factor is produced by human T lymphoblastoid cell line, CEM-ON: identification by amino-terminal amino acid sequence analysis. Biochem Biophys Res Commun 152: 1401–1409
Takatsu K, Harada N, Hara Y, Takahama Y, Yamada G, Dobashi K, Hamaoka T (1985) Purification and physicochemical characterization of murine T cell-replacing factor ( TRF ). J Immunol 134: 382–389
Tao X, Gao G, Zhang H-Z, Zhu D-X, Boersma A, Lamblin G, Han K-K (1987) Isolation and characterization of human urinary colony-stimulating factor. Biol Chem Hoppe Seyler 368: 187–194
Taylor JM, Cohen S, Mitchell WM (1970) Epidermal growth factor: high and low molecular weight forms. Proc Natl Acad Sci USA 67: 164–171
Thomas KA (1988) Transforming potential of fibroblast growth factor genes. Trends Biochem Sci 13: 327–328
Thomas KA, Gimenez-Gallego G (1986) Fibroblast growth factors: broad spectrum mitogens with potent angiogenic activity. Trends Biochem Sci 11: 81–84
Thomas KA, Riley MC, Lemmon SK, Baglan NC, Bradshaw RA (1980) Brain fibroblast growth factor: non-identity with myelin basic protein fragments. J Biol Chem 255: 5517–5520
Todaro GJ, Fryling C, De Larco JE (1980) Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci USA 77: 5258–5262
Todaro GJ, Lee DC, Webb NR, Rose TM, Brown JP (1985) Rat type-a transforming growth factor: structure and possible function as a membrane receptor. In: Feramisco J, Ozanne B, Stiles C (eds) Cancer cells, growth factors and transformation. Cold Spring Harbor Laboratory, Cold Spring Harbor NY
Twardzik DR (1985) Differential expression of transforming growth factor-cc during prenatal development of the mouse. Cancer Res 45: 5413–5416
Twardzik DR, Ranchalis JE, Todaro GJ (1982) Mouse embryonic transforming growth factors related to those isolated from tumor cells. Cancer Res 42: 590–593
Twardzik DR, Kimball ES, Sherwin SA, Ranchalis JE, Todaro GJ (1985) Comparison of growth factors functionally related to epidermal growth factor in the urine of normal and human tumor-bearing athymic mice. Cancer Res 45: 1934–1939
Van Damme J, De Ley M, Opdenakker G, Billiau A, De Somer P (1985) Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1. Nature 314: 266–268
Van Damme J, Van Beumen J, Decock B, Van Snick J, De Ley M, Billiau A (1988) Separation and comparison of two monokines with lymphocyte-activating factor activity: IL-1b and hybridoma growth factor (HGF): identification of leukocyte-derived HGF as IL-6. J Immunol 140: 1534–1541
Van Snick J, Cayphas S, Vink A, Uyttenhove C, Coulie PG, Rubira MR, Simpson RJ (1986) Purification and NH2-terminal amino acid sequence of a T-cell derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci USA 83: 9679–9683
Varon S, Nomura J, Shooter EM (1967) The isolation of the mouse nerve growth factor protein in a high molecular weight form. Biochemistry 6: 2202–2209
Welte K, Wang CY, Mertelsmann R, Venuta S, Feldman SP, Moore MS (1982) Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity. J Exp Med 156: 454–464
Westall FC, Lennon VA, Gospodarowicz D (1978) Brain-derived fibroblast growth factor: identity with a fragment of the basic protein of myelin. Proc Natl Acad Sci USA 75: 4675–4678
Westermark B, Johnsson A, Paulsson Y, Betsholtz C, Heldin C-H, Herlyri M, Rodeck U, Koprowski H (1986) Human melanoma cell lines of primary and metastatic origin express the genes encoding the chains of platelet-derived growth factor ( PDGF) and produce a PDGF-like growth factor. Proc Natl Acad Sci USA 83: 7197–7200
Wilcox JN, Derynck R (1988) Developmental expression of transforming growth factors alpha and beta in mouse fetus. Mol Cell Biol 8: 3415–3422
Wong GG, Witek JS, Temple PA, Wilkens KM, Leary AC, Luxenberg DP, Jones SS, Brown EL, Kay RM, Orr EC, Shoemaker C, Golde DW, Kaufman RJ, Hewick RM, Wang EA, Clark SC (1985) Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science 228: 810–815
Wood DD (1979) Mechanism of action of human B cell-activating factor I. Comparison of the plaque-stimulating activity with thymocyte-stimulating activity. J Immunol 123: 2400–2407
Wu M-C, Cini JK, Yunis AA (1979) Purification of a colony-stimulating factor from cultured pancreatic carcinoma cells. J Biol Chem 254: 6226–6228
Ziltener HJ, Clark-Lewis I, Hood LE, Kent SBH, Schrader JW (1987) Antipeptide antibodies of predetermined specificity recognize and neutralize the bioactivity of the pan-specific hemopoietin interleukin 3. J Immunol 138: 1099–1104
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bradshaw, R.A., Cavanaugh, K.P. (1990). Isolation and Characterization of Growth Factors. In: Sporn, M.B., Roberts, A.B. (eds) Peptide Growth Factors and Their Receptors I. Handbook of Experimental Pharmacology, vol 95 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-49295-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-49295-2_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-49297-6
Online ISBN: 978-3-642-49295-2
eBook Packages: Springer Book Archive